 BRIDGEWATER, N.J., Aug. 5, 2021 PRNewswire -- Insmed Incorporated Nasdaq:INSM, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported financial results for the second quarter ended June 30, 2021 and provided a business update. 